REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 79 filers reported holding REVANCE THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.25 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $274,000 | -86.4% | 10,000 | -84.8% | 0.01% | -86.4% |
| Q1 2018 | $2,020,000 | -9.0% | 65,600 | +5.6% | 0.08% | -17.3% |
| Q4 2017 | $2,220,000 | +252.4% | 62,100 | +171.2% | 0.10% | +206.2% |
| Q3 2017 | $630,000 | +104.5% | 22,900 | +95.7% | 0.03% | +100.0% |
| Q2 2017 | $308,000 | -41.4% | 11,700 | -28.9% | 0.02% | -11.1% |
| Q2 2015 | $526,000 | – | 16,460 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |